ASTRAZENECA PLC
AZN GB0009895292
ICB 2010 : Health Care / Health CareUnited Kingdom CB2 0AA
GB-CAM CAMBRIDGE 1 FRANCIS CRICK AVENUE
CAMBRIDGE BIOMEDICAL CAMPUS
Registration Number 02723534
AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It was involved in developing the OxfordAstraZeneca COVID-19 vaccine.
Founded 1992
Employees 89900
https://astrazeneca.com
https://en.wikipedia.org/wiki/AstraZeneca
Annual Performance 1
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 28% | 32% | -5% | 22% | 0% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Transactions: 10 Insiders: 4
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Michel Demare CB |
100.30 GBP |
2,000 Bought |
200,600 GBP |
15/11/2024 | 15/11/2024 |
| Pascal Soriot CEO |
102.03 GBP |
20,000 Bought |
2,040,600 GBP |
15/11/2024 | 14/11/2024 |
| Philip Broadley DIR |
101.70 GBP |
980 Bought |
99,665 GBP |
13/11/2024 | 13/11/2024 |
| Michel Demare CB |
117.93 GBP |
2,000 Bought |
235,855 GBP |
13/09/2024 | 13/09/2024 |
| Anna Manz DIR |
101.90 GBP |
487 Bought |
49,623 GBP |
18/12/2023 | 12/12/2023 |
| Michel Demare CB |
101.70 GBP |
1,000 Bought |
101,700 GBP |
23/11/2023 | 22/11/2023 |
| Michel Demare CB |
101.05 GBP |
1,000 Bought |
101,052 GBP |
23/11/2023 | 21/11/2023 |
| Michel Demare CB |
117.01 GBP |
2,000 Bought |
234,020 GBP |
02/05/2023 | 28/04/2023 |
| Pascal Soriot CEO |
0.00 GBP |
107,715 Bought |
0 GBP |
15/02/2021 | 11/02/2021 |
| Marc Dunoyer CFO |
0.00 GBP |
6,289 Bought |
0 GBP |
15/02/2021 | 11/02/2021 |